Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Hollywood Bowl shares slump as warm spring dents sales

(Sharecast News) - Shares in Hollywood Bowl slumped on Thursday as the driest UK spring in a century hit sales, although annual guidance was held after a rise in core first-half earnings.

The company on Thursday said earnings before interest, taxes, depreciation, and amortisation rose 2.9% to £49.7m. On an adjusted pre-tax basis earnings were down 9.4% to £49.7m.

"The recent warm and dry weather - marking the driest spring in over a century - has had a short-term impact on trading over that period. In response, we have proactively managed margins and costs, maintaining strong operational performance, which remains at historically high levels," Hollywood Bowl said.

Drier weather earlier in the year between February and late March contributed to a fall in the number of bowling game bookings during its first half to March 31, down 4.5% in the UK on a like-for-like basis. Shares in the firm were down 9% in early London trade.

The fall was also driven by the timing of Easter and last year's leap year, which gave an extra day of trading, "as well as the continuing competition from new competitive socialising offerings opening in certain locations", Hollywood Bowl added.

"Whilst it has been challenging to mitigate the inflationary costs in first half, we are pleased to have achieved this."

"We remain confident in our outlook for the second half of the year. We are well-prepared for the key July and August holiday period and continue to expect full-year EBITDA to fall within the range of current analyst forecasts."

Analysts at Shore Capital maintained a 'buy' rating on the stock, saying they "continue to see material upside from current levels".

"The trading performance remains resilient, free cash flow is robust and set to build to over £50m per annum, return on investment is high, the pipeline is expanding, and management retains a target of 130 centres over the next decade, delivery of which could see EBITDA exceed £100m and underpins our discounted cash flow derived fair value of 400p per share."

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.